Amplified DNA sequences in cancers

Insights

Researchers discovered significant gene amplification beyond known oncogenes in cancer cell lines using a novel in-gel DNA renaturation technique. This method revealed over 400-fold amplification in neuroblastoma, retinoblastoma, and lung carcinoma cells.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Gene amplification is a key mechanism in cancer development.
  • Identifying amplified genes beyond known oncogenes is crucial for understanding tumorigenesis.

Purpose of the Study:

  • To analyze gene amplification beyond known oncogenes in specific cancer cell lines.
  • To evaluate the efficacy of an in-gel DNA renaturation method for detecting gene amplification.

Main Methods:

  • Utilized an in-gel DNA renaturation technique involving radioactively labeled tracer DNA and unlabeled driver DNA.
  • Electrophoresis and subsequent denaturation-renaturation cycles within the gel were employed.
  • Amplified DNA fragments were visualized after two cycles.

Main Results:

  • Demonstrated over 400-fold amplification of various DNA fragments in NB1 (neuroblastoma), Y79 (retinoblastoma), and H69 (small cell lung carcinoma) cell lines.
  • Confirmed 120 to 160-fold amplification of the N-myc gene in these same cell lines.
  • The in-gel renaturation method successfully identified significant gene amplification events.

Conclusions:

  • The study highlights the presence of substantial gene amplification beyond established oncogenes in these cancer types.
  • The in-gel DNA renaturation method is effective for discovering novel amplified DNA regions in cancer genomics.
  • Further investigation into these amplified genes may reveal new therapeutic targets.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...